TMEM37 Activators
TMEM37 activators belong to a class of small molecules that interact with and modulate the function of the TMEM37 protein. TMEM37, also known as Transmembrane protein 37, is a membrane-bound protein primarily found in various cellular compartments, including the endoplasmic reticulum (ER). This protein plays a crucial role in maintaining cellular homeostasis and has been implicated in several cellular processes, although its precise functions are still under investigation. TMEM37 activators are chemical compounds designed to enhance the activity or expression of TMEM37, thereby potentially influencing cellular processes in which this protein is involved.
The exact mechanisms by which TMEM37 activators exert their effects on the TMEM37 protein are still an area of active research. However, it is believed that these activators may interact with specific binding sites on TMEM37 or modify its conformation, leading to increased TMEM37 activity. This modulation of TMEM37 function could have implications for cellular processes such as protein folding, calcium homeostasis, or lipid metabolism, as TMEM37 is known to be involved in these processes. Understanding the precise mechanisms and downstream effects of TMEM37 activation is critical for unraveling the potential biological significance of TMEM37 activators and their relevance in various cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Indirectly enhances TMEM37 activity by disrupting protein trafficking and Golgi organization through interference with small GTPases. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Indirectly activates TMEM37 by inhibiting the mTOR pathway, regulating cellular metabolism and protein trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Indirectly increases TMEM37 activity by inhibiting phosphoinositide 3-kinases (PI3Ks), participating in intracellular signaling and membrane trafficking. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Indirectly activates TMEM37 by potentially affecting endosomal trafficking and autophagy through alterations in endosomal pH. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Indirectly enhances TMEM37 activity by disrupting intracellular transport processes through the depolymerization of microtubules. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Indirectly increases TMEM37 activity by inhibiting N-glycosylation, affecting protein folding and trafficking in the endoplasmic reticulum. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Indirectly activates TMEM37 by inhibiting protein synthesis, impacting protein trafficking and turnover by preventing new protein synthesis. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Indirectly increases TMEM37 activity by inhibiting dynamin, a protein involved in endocytosis and membrane trafficking. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Indirectly activates TMEM37 by acting as a proteasome inhibitor, influencing protein degradation and turnover. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Indirectly enhances TMEM37 activity by inhibiting glycolysis, potentially impacting cellular energy metabolism. | ||||||